What is BioSig Technologies, Inc.'s market cap?

BioSig Technologies, Inc. (STEX) has a market capitalization of $88.7M and trades on NASDAQ.

What is BioSig Technologies, Inc.'s revenue and profitability?

BioSig Technologies, Inc. generated $40.0K in trailing twelve-month revenue with a net loss of $506.7M, representing a net margin of -25825.0%. Gross margin stands at 80.1%. These figures are based on the Q4 2024 filing.

Who are BioSig Technologies, Inc.'s competitors?

BioSig Technologies, Inc.'s key competitors include Tradeweb Markets Inc., Bit Digital, Inc. Ordinary Shares, Greenlane Holdings, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.

Who does BioSig Technologies, Inc. partner with?

BioSig Technologies, Inc.'s notable partners include Monetary Metals & Co., Mayo Foundation for Medical Education and Research, Needham & Company, LLC, and others.

What subsidiaries does BioSig Technologies, Inc. have?

BioSig Technologies, Inc.'s subsidiaries include Streamex Exchange Corporation, ViralClear Pharmaceuticals, Inc., BioSig AI Sciences, Inc..

Where is BioSig Technologies, Inc. headquartered?

BioSig Technologies, Inc. is headquartered in United States of America and employs approximately 5 people. It has been publicly traded since 2014.

BioSig Technologies, Inc.

STEX

Streamex Corp. is a technology company specializing in digital financial infrastructure for the tokenization and lifecycle management of real-world assets (RWAs).

Market cap

$88.66M-61.8%

Revenue$40.0K+122%

Net income-$506.7M-5,102%

EPS (diluted)-$9.71-1,546%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 18, 2026

EPS-$0.27Miss by $0.22

Read the full report

Next report

Aug 11, 2026 (in a month)

Revenue estimate$300.0K

EPS estimate-$0.02

Financials

Q4 2024

Income statement

See full

Revenue$13.0K+8.3%

Operating income-$1.2M+80.8%

Net income-$1.1M+81.8%

EPS (diluted)-$0.03+95.2%

Balance sheet

See full

Cash & equivalents$142.0K-25.3%

Total debt$102.0K-77.4%

Total equity-$1.5M+48.8%

Total assets$842.0K-53.2%

Cash flow

See full

Operating cash flow-$474.0K+83.9%

Valuation & ratios

Valuation

See full

Market cap$88.66M-61.8%

P/S2,216.6×-5,967×

Profitability

See full

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

Returns & leverage

See full

Current ratio0.2×+0.1×

Competitors

By market cap

Medtronic$100.14B-9.1%

Tradeweb Markets Inc.$21.2B-30.9%

TEC

Bio-Techne$11.0B+35.3%

StoneX Group Inc.$9.4B+118%

DigitalBridge Group$2.9B+60.7%

Bit Digital$628.5M-5.7%

BioSig Technologies, Inc.$88.7M-61.8%

Greenlane Holdings, Inc.$1.5M-80.1%

By revenue growth

BioSig Technologies, Inc.+122%

StoneX Group Inc.+38.1%

Tradeweb Markets Inc.+18.3%

DigitalBridge Group-79.1%

By net margin

DigitalBridge Group122.62%—

Tradeweb Markets Inc.40.25%—

StoneX Group Inc.17.6%—

BioSig Technologies, Inc.-25,825.0%-1,212,531pp

Profile

Streamex Corp. is a technology company specializing in digital financial infrastructure for the tokenization and lifecycle management of real-world assets (RWAs). The company provides an institutional-grade platform for the issuance, trading, and custody of digital tokens backed by tangible commodities, while maintaining a legacy biomedical technology business focused on advanced signal processing for cardiac electrophysiology.

Competitive position

Streamex is an early-stage entrant in the RWA tokenization market, pivoting from a legacy medical device background to focus on gold-backed digital assets.

GeographiesUnited States, Canada, Cayman Islands

Customer segmentsInstitutional investors, Accredited investors, Healthcare providers

Business modelInfrastructure-as-a-Service, Transaction-based fees, Licensing, Asset Management

SuppliersLBMA-accredited gold custodians, Blockchain network protocols, Special Purpose Vehicle (SPV) administrators, Software developers

CustomersQualified institutional buyers, Accredited retail investors, Cardiac surgery centers

CountryUnited States of America

Listed2014

Employees5.0

CEOKarl Henry McPhie

SectorHealthcare

IndustryMedical - Devices

Websitestreamex.com

FilingsSEC EDGAR

Ask your AI about BioSig Technologies, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s market cap?: BioSig Technologies, Inc. (STEX) has a market capitalization of $88.7M and trades on NASDAQ.
What is BioSig Technologies, Inc.'s revenue and profitability?: BioSig Technologies, Inc. generated $40.0K in trailing twelve-month revenue with a net loss of $506.7M, representing a net margin of -25825.0%. Gross margin stands at 80.1%. These figures are based on the Q4 2024 filing.
Who are BioSig Technologies, Inc.'s competitors?: BioSig Technologies, Inc.'s key competitors include Tradeweb Markets Inc., Bit Digital, Inc. Ordinary Shares, Greenlane Holdings, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.
Who does BioSig Technologies, Inc. partner with?: BioSig Technologies, Inc.'s notable partners include Monetary Metals & Co., Mayo Foundation for Medical Education and Research, Needham & Company, LLC, and others.
What subsidiaries does BioSig Technologies, Inc. have?: BioSig Technologies, Inc.'s subsidiaries include Streamex Exchange Corporation, ViralClear Pharmaceuticals, Inc., BioSig AI Sciences, Inc..
Where is BioSig Technologies, Inc. headquartered?: BioSig Technologies, Inc. is headquartered in United States of America and employs approximately 5 people. It has been publicly traded since 2014.